© Drug Hunter Inc. 2018-2023
Home > ACT-1004-1239
CXCR7 GPCR insurmountable antagonist
target engagement in rodent, 61% F in dog
from 300k HTS vs. _-arrestin recruitment, opt.
J. Med. Chem., Dec. 14, 2020
Idorsia Pharma (Actelion), Allschwil, CH
Idorsia/Actelion CXCR7 GPCR insurmountable antagonist
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
Molecules of the Month
Molecule of the Year